Effects of a 20-Week School-Based Periodized Strength Training Program on Motor Performance in Children

NCT07690072 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2026-07-08

No results posted yet for this study

Summary

Regular physical activity and supervised strength training are recognized components of healthy growth and motor development during childhood. Although linear and nonlinear periodized strength training are widely used approaches for organizing resistance training, limited information is available regarding their comparative application in school-aged children, particularly within school-based programs. This randomized controlled trial compares two periodized strength training models implemented over a 20-week intervention in schoolchildren to assess muscular power and speed/agility using standardized motor performance assessments.

Conditions

  • Aimed to Examine the Effects of Linear and Nonlinear Periodized Strength Training on Motor Performance in Schoolchildren

Interventions

BEHAVIORAL

Periodized Strength Training in Schoolchildren

Participants completed a 20-week school-based periodized strength training program conducted during extracurricular sessions three times per week. Participants were assigned to either a linear periodization group or a nonlinear periodization group. The program aimed to improve motor performance through structured strength training exercises adapted to school-aged children.

Sponsors & Collaborators

  • Universidad de Pamplona

    lead OTHER

Principal Investigators

  • Dennis G Contreras, Doctor · Universidad de Pamplona

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
14 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-14
Primary Completion
2023-07-01
Completion
2023-07-15

Countries

  • Colombia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07690072 on ClinicalTrials.gov